Half-time of maximal response (p < 0.05) and amplitude (p < 0.001) were significantly reduced in the HCs compared with the ME/CFS patients following TRPM7 desensitisation. This evidence concerns the gene TRPM7 and myalgic encephalomeyelitis/chronic fatigue syndrome.